Company news

Seres Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Seres Therapeutics Appoints Terri Young, Ph.D., R.Ph., Experienced Commercial Leader, as Executive Vice President, Chief Commercial and Strategy Officer

June 21, 2020

Seres Therapeutics to Host Virtual SER-109 Focused Symposium on May 27, 2020, Ahead of Phase 3 ECOSPOR III Study Read-Out

May 17, 2020

Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates

May 6, 2020

Seres Therapeutics Appoints Lisa von Moltke, M.D., as Chief Medical Officer

April 5, 2020

Seres Therapeutics Announces Completion of Enrollment in SER-109 Phase 3 ECOSPOR III Study for Recurrent Clostridium difficile Infection and Provides Clinical Pipeline Updates

March 29, 2020

Seres Therapeutics Appoints Paul Biondi, Experienced Biopharmaceutical Strategy and Corporate Development Professional, to Its Board of Directors

March 22, 2020

Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration’s March 12, 2020 Safety Alert Related to Use of Fecal Microbiota Transplantation

March 12, 2020

Seres Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Highlights

March 1, 2020

Seres Therapeutics Appoints Stephen Berenson as Chairman of its Board of Directors

December 15, 2019

Seres Therapeutics Reports Third Quarter Financial Results and Provides Business Update

November 4, 2019

← Newer news releases

Calls

The 5 newest of 20 calls. Every call is listed under its year.

Decks

The 5 newest of 54 decks. Every deck is listed under its year.